Global Veterinary Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Veterinary Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

According to APO Research, The global Veterinary Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
BioTestLab
RVSRI
Medion
Veterinary Vaccine segment by Type

Live Attenuated Vaccines
Inactivated Vaccines
Others
Veterinary Vaccine segment by Application

Livestock
Swine
Chicken
Dog & Cat
Others
Veterinary Vaccine by Distribution Channel

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Veterinary Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Veterinary Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Veterinary Vaccine Market by Type
1.3.1 Live Attenuated Vaccines
1.3.2 Inactivated Vaccines
1.3.3 Others
1.4 Global Veterinary Vaccine Market Size by Type
1.4.1 Global Veterinary Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Veterinary Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Veterinary Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Veterinary Vaccine Revenue (2019-2024)
3.2 Global Top Players by Veterinary Vaccine Sales (2019-2024)
3.3 Global Top Players by Veterinary Vaccine Price (2019-2024)
3.4 Global Veterinary Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Veterinary Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Veterinary Vaccine Company, Product Type & Application
3.7 Global Veterinary Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Veterinary Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier 3
4 Veterinary Vaccine Regional Status and Outlook
4.1 Global Veterinary Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Veterinary Vaccine Historic Market Size by Region
4.2.1 Global Veterinary Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Veterinary Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Veterinary Vaccine Forecasted Market Size by Region
4.3.1 Global Veterinary Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Veterinary Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Veterinary Vaccine by Application
5.1 Veterinary Vaccine Market by Application
5.1.1 Livestock
5.1.2 Swine
5.1.3 Chicken
5.1.4 Dog & Cat
5.1.5 Others
5.2 Global Veterinary Vaccine Market Size by Application
5.2.1 Global Veterinary Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Veterinary Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Veterinary Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Merck
6.1.1 Merck Comapny Information
6.1.2 Merck Business Overview
6.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Veterinary Vaccine Product Portfolio
6.1.5 Merck Recent Developments
6.2 Zoetis
6.2.1 Zoetis Comapny Information
6.2.2 Zoetis Business Overview
6.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Veterinary Vaccine Product Portfolio
6.2.5 Zoetis Recent Developments
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Comapny Information
6.3.2 Boehringer Ingelheim Business Overview
6.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments
6.4 Ceva
6.4.1 Ceva Comapny Information
6.4.2 Ceva Business Overview
6.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Veterinary Vaccine Product Portfolio
6.4.5 Ceva Recent Developments
6.5 CAHIC
6.5.1 CAHIC Comapny Information
6.5.2 CAHIC Business Overview
6.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CAHIC Veterinary Vaccine Product Portfolio
6.5.5 CAHIC Recent Developments
6.6 HVRI
6.6.1 HVRI Comapny Information
6.6.2 HVRI Business Overview
6.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HVRI Veterinary Vaccine Product Portfolio
6.6.5 HVRI Recent Developments
6.7 Ringpu Biology
6.7.1 Ringpu Biology Comapny Information
6.7.2 Ringpu Biology Business Overview
6.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
6.7.5 Ringpu Biology Recent Developments
6.8 Yebio
6.8.1 Yebio Comapny Information
6.8.2 Yebio Business Overview
6.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Yebio Veterinary Vaccine Product Portfolio
6.8.5 Yebio Recent Developments
6.9 DHN
6.9.1 DHN Comapny Information
6.9.2 DHN Business Overview
6.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 DHN Veterinary Vaccine Product Portfolio
6.9.5 DHN Recent Developments
6.10 WINSUN
6.10.1 WINSUN Comapny Information
6.10.2 WINSUN Business Overview
6.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WINSUN Veterinary Vaccine Product Portfolio
6.10.5 WINSUN Recent Developments
6.11 Elanco
6.11.1 Elanco Comapny Information
6.11.2 Elanco Business Overview
6.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elanco Veterinary Vaccine Product Portfolio
6.11.5 Elanco Recent Developments
6.12 Virbac
6.12.1 Virbac Comapny Information
6.12.2 Virbac Business Overview
6.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Virbac Veterinary Vaccine Product Portfolio
6.12.5 Virbac Recent Developments
6.13 Jinyu Bio-Technology
6.13.1 Jinyu Bio-Technology Comapny Information
6.13.2 Jinyu Bio-Technology Business Overview
6.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
6.13.5 Jinyu Bio-Technology Recent Developments
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Comapny Information
6.14.2 ChengDu Tecbond Business Overview
6.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments
6.15 CAVAC
6.15.1 CAVAC Comapny Information
6.15.2 CAVAC Business Overview
6.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CAVAC Veterinary Vaccine Product Portfolio
6.15.5 CAVAC Recent Developments
6.16 Kyoto Biken Laboratories
6.16.1 Kyoto Biken Laboratories Comapny Information
6.16.2 Kyoto Biken Laboratories Business Overview
6.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
6.16.5 Kyoto Biken Laboratories Recent Developments
6.17 FATRO
6.17.1 FATRO Comapny Information
6.17.2 FATRO Business Overview
6.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 FATRO Veterinary Vaccine Product Portfolio
6.17.5 FATRO Recent Developments
6.18 Vaksindo
6.18.1 Vaksindo Comapny Information
6.18.2 Vaksindo Business Overview
6.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Vaksindo Veterinary Vaccine Product Portfolio
6.18.5 Vaksindo Recent Developments
6.19 Bio-Labs
6.19.1 Bio-Labs Comapny Information
6.19.2 Bio-Labs Business Overview
6.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
6.19.5 Bio-Labs Recent Developments
6.20 Avimex Animal Health
6.20.1 Avimex Animal Health Comapny Information
6.20.2 Avimex Animal Health Business Overview
6.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
6.20.5 Avimex Animal Health Recent Developments
6.21 MEVAC
6.21.1 MEVAC Comapny Information
6.21.2 MEVAC Business Overview
6.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 MEVAC Veterinary Vaccine Product Portfolio
6.21.5 MEVAC Recent Developments
6.22 Biovac
6.22.1 Biovac Comapny Information
6.22.2 Biovac Business Overview
6.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Biovac Veterinary Vaccine Product Portfolio
6.22.5 Biovac Recent Developments
6.23 Atafen
6.23.1 Atafen Comapny Information
6.23.2 Atafen Business Overview
6.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Atafen Veterinary Vaccine Product Portfolio
6.23.5 Atafen Recent Developments
6.24 Dyntec
6.24.1 Dyntec Comapny Information
6.24.2 Dyntec Business Overview
6.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Dyntec Veterinary Vaccine Product Portfolio
6.24.5 Dyntec Recent Developments
6.25 BioTestLab
6.25.1 BioTestLab Comapny Information
6.25.2 BioTestLab Business Overview
6.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.25.4 BioTestLab Veterinary Vaccine Product Portfolio
6.25.5 BioTestLab Recent Developments
6.26 RVSRI
6.26.1 RVSRI Comapny Information
6.26.2 RVSRI Business Overview
6.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.26.4 RVSRI Veterinary Vaccine Product Portfolio
6.26.5 RVSRI Recent Developments
6.27 Medion
6.27.1 Medion Comapny Information
6.27.2 Medion Business Overview
6.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Medion Veterinary Vaccine Product Portfolio
6.27.5 Medion Recent Developments
7 North America by Country
7.1 North America Veterinary Vaccine Sales by Country
7.1.1 North America Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Veterinary Vaccine Sales by Country (2019-2024)
7.1.3 North America Veterinary Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Veterinary Vaccine Market Size by Country
7.2.1 North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Veterinary Vaccine Market Size by Country (2019-2024)
7.2.3 North America Veterinary Vaccine Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Veterinary Vaccine Sales by Country
8.1.1 Europe Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Veterinary Vaccine Sales by Country (2019-2024)
8.1.3 Europe Veterinary Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Veterinary Vaccine Market Size by Country
8.2.1 Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Veterinary Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Veterinary Vaccine Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Veterinary Vaccine Sales by Country
9.1.1 Asia-Pacific Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Veterinary Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Veterinary Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Veterinary Vaccine Market Size by Country
9.2.1 Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Veterinary Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Veterinary Vaccine Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Veterinary Vaccine Sales by Country
10.1.1 Latin America Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Veterinary Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Veterinary Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Veterinary Vaccine Market Size by Country
10.2.1 Latin America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Veterinary Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Veterinary Vaccine Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Veterinary Vaccine Sales by Country
11.1.1 Middle East and Africa Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Veterinary Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Veterinary Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Veterinary Vaccine Market Size by Country
11.2.1 Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Veterinary Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Veterinary Vaccine Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Veterinary Vaccine Value Chain Analysis
12.1.1 Veterinary Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Veterinary Vaccine Production Mode & Process
12.2 Veterinary Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Veterinary Vaccine Distributors
12.2.3 Veterinary Vaccine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings